CHEK2 1100delC is prevalent in Swedish early onset familial breast cancer

BACKGROUND: A truncating variant, 1100delC, in check point-kinase CHEK2, has been identified as a risk factor for familial and sporadic breast cancer. The prevalence in healthy non-breast cancer cases is low and varies between populations. METHODS: We analyzed the prevalence of CHEK2 1100delC in 763...

Descripción completa

Detalles Bibliográficos
Autores principales: Margolin, Sara, Eiberg, Hans, Lindblom, Annika, Bisgaard, Marie Luise
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1994956/
https://www.ncbi.nlm.nih.gov/pubmed/17705858
http://dx.doi.org/10.1186/1471-2407-7-163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1994956/
https://www.ncbi.nlm.nih.gov/pubmed/17705858
http://dx.doi.org/10.1186/1471-2407-7-163

Ejemplares similares